Product Information
AMINOCAPROIC ACID 1,000 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $8.3122 per EA under NDC 00054111013. Its NADAC has been published 72 times since Feb 12, 2025.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054111013
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMINOCAPROIC ACIDApproval Type
Authorized Generic (NDA)
FDA Application
NDA015197FDA Approved
Before 1982
TE Code
AB
On Market Since
3/12/2019
Pharmacological Classes
Price Statistics
The NADAC for AMINOCAPROIC ACID 1,000 MG TAB has been published 72 times since Feb 12, 2025, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3122 per EA |
|---|---|
| All-time high | $10.5331 (Apr 16, 2025) |
| All-time low | $8.2148 (Apr 23, 2025) |
| 52-week high | $8.3122 |
| 52-week low | $8.2148 |
| Median price | $8.2148 |
| Average price | $8.5395 |
| Largest weekly change | -22.0% (Apr 23, 2025) |
| Weeks tracked | 72 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aminocaproic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMINOCAPROIC ACID 1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMINOCAPROIC ACID 1,000 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $8.3122 per EA (NDC 00054111013), effective Sep 30, 2026.
How has the price of AMINOCAPROIC ACID 1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for AMINOCAPROIC ACID 1,000 MG TAB has declined 21.1%. It has been tracked across 72 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for AMINOCAPROIC ACID 1,000 MG TAB?
Since Feb 12, 2025, the NADAC for AMINOCAPROIC ACID 1,000 MG TAB has ranged from a low of $8.2148 (Apr 23, 2025) to a high of $10.5331 (Apr 16, 2025), with a median of $8.2148 per EA.
Are there cheaper alternatives to AMINOCAPROIC ACID 1,000 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMINOCAPROIC ACID 1,000 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMINOCAPROIC ACID 1,000 MG TAB?
AMINOCAPROIC ACID 1,000 MG TAB (NDC 00054111013) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.